Physician
Rheumatology
Dr. Timothy B. Niewold, MD
|
|
Give Review
Timothy Niewold practices Rheumatology. He researched medicine at University of Illinois College of Medicine. He received 2 awards: "Fellow (FACR)" and "Fellow". Dr. Timothy B. Niewold has written publications. He has 100 publications published with PubMed. The lastest paper is: 'Increased pretreatment serum IFN-/ ratio predicts non-response to tumour necrosis factor inhibition in rheumatoid arthritis.' Timothy Niewold accepts Medicare payments and is registered with Medicare.gov.
Publications
- Immunogenetics of systemic lupus erythematosus: A comprehensive review.
- Increased pretreatment serum IFN-β/α ratio predicts non-response to tumour necrosis factor α inhibition in rheumatoid Arthritis.
- Immunological Biomarkers in Dermatomyositis.
- Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study.
- The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon.
- Sirukumab : a novel therapy for lupus nephritis?
- Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA.
- The IRF5-TNPO3 association with systemic lupus erythematosus (SLE) has two components that other autoImmune disorders variably share.
- Two Functional Lupus-Associated BLK Promoter Variants Control Cell-Type- and Developmental-Stage-Specific Transcription.
- Combined protein- and nucleic acid-level effects of rs1143679 (R77H), a lupus-predisposing variant within ITGAM.
- End-Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1.
- Genetics of the type I interferon pathway in systemic lupus erythematosus.
- Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression.
- End-stage kidney Disease in African Americans with lupus nephritis associates with APOL1.
- Brief Report: Interferon-α Induction and Detection of Anti-Ro, Anti-La, Anti-Sm, and Anti-RNP Autoantibodies by Autoantigen Microarray Analysis in Juvenile Dermatomyos...
- Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis.
- Variable Association of Reactive Intermediate Genes with Systemic Lupus Erythematosus in Populations with Different African Ancestry.
- Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups.
- MicroRNA-3148 Modulates Allelic Expression of Toll-Like Receptor 7 Variant Associated with Systemic Lupus Erythematosus.
- Admixture Mapping in Lupus Identifies Multiple Functional Variants within IFIH1 Associated with Apoptosis, Inflammation, and Autoantibody Production.
- Circulating cytokines in sarcoidosis: Phenotype-specific alterations for fibrotic and non-fibrotic pulmonary Disease.
- Autoimmune Disease genetics.
- Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus.
- Two independent functional risk haplotypes in TNIP1 are associated with systemic lupus erythematosus.
- Impact of genetic ancestry and socio-demographic status on the clinical expression of systemic lupus erythematosus in Amerindian-European populations.
- Brief Report: IRF5 systemic lupus erythematosus risk haplotype is associated with asymptomatic serologic autoimmunity and progression to clinical autoimmunity in mothe...
- Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus.
- Functional genetic polymorphisms in ILT3 are associated with decreased surface expression on dendritic cells and increased serum cytokines in lupus patients.
- Genetic ancestry, serum interferon-α activity, and autoantibodies in systemic lupus erythematosus.
- B lymphocyte stimulator levels in systemic lupus erythematosus: Higher circulating levels in African American patients and increased production after influenza vaccina...
- IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with sys...
- The Autoimmune Disease Risk Allele of UBE2L3 in African American Patients with Systemic Lupus Erythematosus: A Recessive Effect Upon Subphenotypes.
- Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis.
- Interferon Alpha as a Primary Pathogenic Factor in Human Lupus.
- Autoimmune Disease Risk Variant of IFIH1 Is Associated with Increased Sensitivity to IFN-{alpha} and Serologic Autoimmunity in Lupus Patients.
- Interferon regulatory factors in human lupus pathogenesis.
- Bone health issues in Sarcoidosis.
- Influenza vaccination Responses in human systemic lupus erythematosus: impact of clinical and demographic features.
- Vitamin D deficiency is associated with an increased autoImmune response in healthy individuals and in patients with systemic lupus erythematosus.
- Familial aggregation of autoimmune Disease in juvenile dermatomyositis.
- Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus.
- The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies.
- Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus.
- Linkage of Type I Interferon Activity and TNF-Alpha Levels in Serum with Sarcoidosis Manifestations and Ancestry.
- Drug-induced granulomatous interstitial nephritis in a patient with Ankylosing spondylitis during therapy with adalimumab.
- Gene-gene-sex interaction in cytokine gene polymorphisms revealed by serum interferon alpha phenotype in juvenile Dermatomyositis.
- Lesional and nonlesional skin from patients with untreated juvenile Dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells.
- Rheumatologic manifestations of Sarcoidosis.
- African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity.
- Lenalidomide for the treatment of cryoglobulinemia and undifferentiated spondyloarthropathy in a patient with multiple myeloma.
- Genetic regulation of serum cytokines in systemic lupus erythematosus.
- Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.
- The role of genetic variation near interferon-kappa in systemic lupus erythematosus.
- Cytokines in systemic lupus erythematosus.
- Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe Disease manifestations.
- Interferon alpha in systemic lupus erythematosus.
- Promoter variant of PIK3C3 is associated with autoimmunity against Ro and Sm epitopes in African-American lupus patients.
- Clinical characteristics of patients with anti-Jo-1 antibodies: a single center experience.
- Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with Disease activity at diagnosis and after thirty-six months of therapy.
- Cutting edge: autoimmune Disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo.
- The PTPN22 C1858T polymorphism is associated with skewing of cytokine profiles toward high interferon-alpha activity and low tumor necrosis factor alpha levels in pati...
- Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients.
- Age- and sex-related patterns of serum interferon-alpha activity in lupus families.
- Interferon alpha-induced lupus: proof of principle.
- Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus.
- Augmented interferon-alpha pathway activation in patients with Sjögren's Syndrome treated with etanercept.
- Concomitant interferon-alpha therapy and tumor necrosis factor alpha inhibition for rheumatoid Arthritis and hepatitis C.
- Disseminated intravascular coagulation due to cytomegalovirus infection in an immunocompetent adult treated with plasma exchange.
- 59-year-old woman with progressive dyspnea on exertion.
- 78-year-old woman with fever, weight loss, and rash.
- 27-Year-old woman with numbness and weakness of the extremities.
- Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients.
- Dysregulation of antiviral helicase pathways in systemic lupus erythematosus.
- Nucleic Acid Sensors and Type I Interferon Production in Systemic Lupus Erythematosus.
- PTPN22 Association in Systemic Lupus Erythematosus (SLE) with Respect to Individual Ancestry and Clinical Sub-Phenotypes.
- Familial aggregation of high tumor necrosis factor alpha levels in systemic lupus erythematosus.
- Increased serum type I interferon activity in organ-specific autoImmune disorders: clinical, imaging, and serological associations.
- Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus.
- Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus.
- Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study.
- Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility.
- Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups.
- Ocrelizumab: a step forward in the evolution of B-cell therapy.
- Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus.
- Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus.
- Ribosomal and Immune Transcripts Associate with Relapse in Acquired ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura.
- Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus.
- Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study.
- A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients.
- Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid Arthritis.
- Rituximab treatment of thrombotic thrombocytopenic purpura in the setting of connective tissue Disease.
- Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with Hepatitis C.
- CheB is required for behavioural Responses to negative stimuli during chemotaxis in Bacillus subtilis.
- Post-streptococcal reactive Arthritis and glomerulonephritis in an adult.
- Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid Arthritis.
- High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus.
- Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus.
- Exposure to nuclear antigens contributes to the induction of humoral autoimmunity during tumour necrosis factor alpha blockade.
- Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort.
Schools
University of Illinois At Chicago College of Medicine
Procedures Preformed
- Joint Drainage
- Steroid Injection
- Viscosupplementation With Hyaluronate
Conditions Treated
- Ankylosing Spondylitis
- Arthritis
- Bursitis
- Calcium Pyrophosphate Dihydrate Deposition Disease (CPPD)
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- Fellow (FACR)
- Fellow
Education
-
New York Presbyterian Hospital -
Mayo School of Graduate Medical Education -
University of Illinois College of Medicine
Hospital
-
University of Chicago Medical Center -
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1922129279 | |
| NPPES Provider LastName | NIEWOLD | |
| NPPES Provider FirstName | TIMOTHY | |
| NPPES Provider ZIPCode | 606371447 | |
| NPPES Provider State | IL | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 45.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1922129279 |
| Last Name Of The Provider | NIEWOLD |
| First Name Of The Provider | TIMOTHY |
| View All |
Similar Doctors
|
|
Dr. Shreyasee M. Amin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harvinder S. Luthra, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. George L. Allen, MD |
|
|
Dr. Sherine E. Gabriel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Uma Thanarajasingam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Audrey M. Nelson, MD |
|
|
Dr. Jackie A. Clowes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prabhu D. Udayakumar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew J. Koster, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nisha J. Manek, MD
This Doctor is OpenDoctor Recommended.
|